Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AUPH - Aurinia Pharmaceuticals Inc

IEX Last Trade
6.81
-0.090   -1.322%

Share volume: 1,127,663
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$6.90
-0.09
-1.30%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
13%
Profitability 0%
Dept financing 4%
Liquidity 50%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.74%
1 Month
21.17%
3 Months
26.58%
6 Months
16.61%
1 Year
-25.49%
2 Year
-9.32%
Key data
Stock price
$6.81
P/E Ratio 
0.00
DAY RANGE
$6.72 - N/A
EPS 
$0.00
52 WEEK RANGE
$4.71 - $10.24
52 WEEK CHANGE
-$0.28
MARKET CAP 
971.539 M
YIELD 
N/A
SHARES OUTSTANDING 
142.664 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
BETA 
1.22
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,466,586
AVERAGE 30 VOLUME 
$1,549,535
Company detail
CEO: Peter Greenleaf
Region: US
Website: https://www.auriniapharma.com
Employees: 337
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

aurinia pharmaceuticals is a biotechnology company located in 5120-75 street, edmonton, canada.

Recent news